(Press-News.org) OKLAHOMA CITY – In a study published Wednesday in the Proceedings of the National Academy of Sciences (PNAS), University of Oklahoma researchers detail their discoveries about why the brain tumor glioblastoma is so aggressive. Their findings center on ZIP4, a protein that transports zinc throughout the body and sets off a cascade of events that drive tumor growth.
About half of all malignant brain tumors are glioblastomas, the deadliest form of brain cancer with a median survival rate of 14 months.
“Surgery for glioblastoma is very challenging, and patients almost always experience a relapse,” said the study’s senior author, Min Li, Ph.D., a professor of medicine, surgery and cell biology at the University of Oklahoma College of Medicine. “By better understanding why these brain tumors are so aggressive, we hope to open up paths for new treatments.”
Under normal conditions, ZIP4 plays a positive role, transporting and maintaining the right amount of zinc for good health. However, when brain cancer is present, ZIP4 takes on a different role. In the case of glioblastoma, it triggers a series of events:
Glioblastoma takes in about 10 times more zinc than normal brain tissue does.
Glioblastoma with abundant ZIP4 releases tiny bubble-like packages called extracellular vesicles (EVs).
Inside the EVs is a protein called TREM1, which normally helps the immune system fight infection, but in this case turns nearby brain immune cells (called microglia) into supporters of tumor growth.
These microglia release chemicals that allow the tumor to grow.
“Everything starts with the fact that ZIP4 is overexpressed in glioblastoma,” Li said. “That triggers all these downstream events that help the tumor to grow.”
Li’s research team also tested a small-molecule inhibitor to target ZIP4 and TREM1. The inhibitor attached to both proteins, stopping their actions and slowing tumor growth. “This tells us that ZIP4 and TREM1 may be promising therapeutic targets,” he said.
Neurosurgeon, OU College of Medicine Executive Dean and study co-author Ian Dunn, M.D., said the findings are an encouraging step toward combating the aggressive cancer.
“These results are really exciting in such a debilitating cancer. The hope and promise is to translate these findings to novel treatment approaches to improve the lives of our patients,” said Dunn, who has been treating patients with brain tumors for over 20 years.
This is one of Li’s first major publications on glioblastoma, but ZIP4 has been a focus of his pancreatic cancer research for many years. He discovered that overexpression of ZIP4 causes pancreatic cancer cells to be more resistant to chemotherapy and prompts tumor cells to transform themselves so they can stealthily travel to the body’s other organs. In addition, he found that ZIP4 plays a role in the onset of cachexia, a muscle-wasting condition that affects the majority of patients with pancreatic cancer.
###
About the Project
The paper, “A zinc transporter drives glioblastoma progression via extracellular vesicles–reprogrammed microglial plasticity,” can be found at https://www.pnas.org/doi/10.1073/pnas.2427073122. Other OU authors include Kar-Ming Fung, M.D., Ph.D., Chao Xu, Ph.D., James Battiste, M.D., Michael Bronze, M.D., and Courtney Houchen, M.D. Co-senior author Webster Cavenee, Ph.D., is from the University of California at San Diego. Additional authors are from several institutions in China.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university with campuses in Norman, Oklahoma City and Tulsa. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. In Oklahoma City, OU Health Sciences is one of the nation’s few academic health centers with seven health profession colleges located on the same campus. OU Health Sciences serves approximately 4,000 students in more than 70 undergraduate and graduate degree programs spanning Oklahoma City and Tulsa and is the leading research institution in Oklahoma. For more information about OU Health Sciences, visit www.ouhsc.edu.
END
Imagine trying to tell identical twins apart just by looking at their fingerprints. That’s how challenging it can be for scientists to distinguish the tiny powdery pollen grains produced by fir, spruce and pine trees.
But a new artificial intelligence system developed by researchers at The University of Texas at Arlington, the University of Nevada and Virginia Tech is making that task a lot easier—and potentially bringing big relief to allergy sufferers.
“With more detailed data on which tree species are most allergenic and ...
UNIVERSITY PARK, Pa. — In the United States, syphilis cases rose by nearly 80% between 2018 and 2023, with 209,253 cases reported in the latest year of data. The infection, which can be transmitted sexually or passed from mother to infant during birth, is curable but only if diagnosed quickly. Left untreated, syphilis can progress from painless lesions to brain and cardiovascular damage. Despite the first recorded outbreak of syphilis occurring more than 500 years ago — with some researchers theorizing that it has plagued humans for thousands of years — there still isn’t a way to quickly and reliably test for active ...
COLUMBUS, Ohio – After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have shown in a new study how activity of “good” microbes in the gut is linked to rheumatoid arthritis and, potentially, other autoimmune diseases.
Scientists first reported in 2016 that specific gut microbes known as commensal bacteria, which cause no harm and often contribute to host health, set off production and release of a gut-originated T cell that drives up body-wide autoimmune disease in mice. Since then, the team has focused on explaining this unexpected twist in the typically harmonious ...
Washington, D.C. – May 1, 2025 – New clinical results from multiple studies show coronary heart disease death associated with tobacco use is anticipated to rise up to 40% in the next five years and people with cannabis use disorder are 50% more likely to experience cardiogenic shock, acute myocardial infarction, and arrhythmias. These studies were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions.
Tobacco and cannabis are two of the most used substances in ...
Urgent action must be taken to reduce the ever-rising number of people killed by extreme temperatures in India, say the authors of a new 19-year study which found that 20,000 people died from heatstroke in the last two decades. Cold exposure claimed another 15,000 lives.
Findings published today in the peer-reviewed journal Temperature, also revealed that deaths from heatstroke are more common in men of working age and identified the states that are hotspots for deaths from heatstroke and from hypothermia and other conditions fuelled by the cold.
There is an upward moving, increasing trend ...
Psychotherapy assumed a larger role in outpatient mental health care while psychiatric medication without psychotherapy became less common, according to a new study at Columbia University Mailman School of Public Health and Columbia University Irving Medical Center. The findings are published in the American Journal of Psychiatry.
“After years of American mental health care moving towards greater use of psychiatric medications, the pendulum has started swinging back towards psychotherapy,” said Mark Olfson, MD, MPH, Columbia Mailman ...
WASHINGTON, D.C., May 1, 2025 — The latest issues of three American Psychiatric Association journals (The American Journal of Psychiatry, Psychiatric Services and Focus) are now available online.
The May issue of The American Journal of Psychiatry brings together new research on diverse treatment strategies. Highlights of the issue include:
Randomized Controlled Trial of Bounce Back Now, a Mobile Application to Reduce Post-Disaster Symptoms of Posttraumatic Stress, Depressed Mood, and Sleep Disturbance. (Lead author Kenneth J. Ruggiero, Ph.D., is the guest on May's AJP Audio podcast episode, and AJP Deputy Editor Daniel Pine, M.D. highlights ...
More than 1,200 physicists from around the world will convene to present new research at the 56th Annual Meeting of the American Physical Society’s Division of Atomic, Molecular and Optical Physics. The conference will be held in person only at the Oregon Convention Center in Portland, Oregon June 16-20.
Press registration
News media with valid APS press credentials may register for the meeting at no cost. To request press credentials, visit APS’ online newsroom. Registration will remain open throughout the meeting.
Housing information
Discounted hotel rates are available at select hotels near the Oregon Convention Center. Book ...
A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments.
The proof-of-concept study, published today in Science, introduced a mechanism called ‘GlycoCaging’ that releases medicine exclusively to the lower gut at doses up to 10 times lower than current therapies.
“With this technique, we have the ability to deliver not just steroids, but a range of drugs including anti-microbial compounds directly to the gut, ...
A partnership announced in January between the American Association for the Advancement of Science (AAAS) and Arizona State University (ASU) includes a new prize for early-career scientists whose research focuses on societal impact. As of 1 May, this prize, developed with AAAS’s flagship peer-reviewed journal, Science, is open for submissions.
The ASU-Science Prize for Transformational Research will be awarded to a researcher who uses new methods to identify problems and produce findings with impacts ...
